W.EgeciogluE.et al (2015)
Because retatrutide is not yet licensed in the UK, it is not routinely available for prescribing outside a clinical trial or a specific MHRA access scheme (such as the Early Access to Medicines Scheme [EAMS] or named-patient unlicensed supply)
Semaglutide itself does not directly raise potassium, but dehydration from reduced food intake can concentrate electrolytes
Common side effects may include nausea, headache, dizziness, fatigue, gastrointestinal discomfort, sleep changes, or changes in appetite
Experiment 2: semaglutide administered on water days To determine whether the effects of semaglutide on discrimination performance were specific to the alcohol discriminative stimulus cue, a new cohort of rats (7 males and 3 females) underwent discrimination training
J Hepatol 69(2):385395